Showing results (551-560 of 1,014) with videos related to
Sort By:
Pageof 102
The Journal of Pharmacy and Pharmacology|July 1, 1984
Dopamine receptor binding sites in the rat superior colliculusJ K Chivers, M D Hall, E Kelly, et al.Neuroscience Letters|July 19, 1988
Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicityJ Willoughby, V Glover, M Sandler, et al.Journal of Neurology|February 1, 1992
Brain muscarinic cholinergic receptors in Huntington's diseaseK W Lange, F Javoy-Agid, Y Agid, et al.Neuroscience Letters|March 20, 1987
Age-related decreases in the concentration of Met- and Leu-enkephalin and neurotensin in the basal ganglia of ratsM L De Ceballos, S Boyce, M Taylor, et al.The Journal of Pharmacy and Pharmacology|July 1, 1976
Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnoverS R Snider, C Hutt, B Stein, et al.Pharmacology, Biochemistry, and Behavior|April 1, 1989
The protein synthesis inhibitor, anisomycin, causes exacerbation of the iminodipropionitrile-induced spasmodic dyskinetic syndrome in ratsR Stennett, M Katz, V Jackson-Lewis, et al.Psychopharmacology|January 1, 1985
Attenuation by electroshock treatment of the haloperidol-induced rise in the binding of 3H-imipramine to rat brain membranesA I Barkai, S Kowalik, A Reches, et al.The Laryngoscope|February 1, 1992
Abductor laryngeal dystonia: a series treated with botulinum toxinA Blitzer, M F Brin, C Stewart, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|March 14, 1977
Is dopamine a neurohormone of the adrenal medulla? Studies with morphine stimulationS R Snider, C Miller, A L Prasad, et al.Life Sciences|January 1, 1989
Monoamine oxidase inhibitory properties of milacemide in ratsD D Truong, B Diamond, G Pezzoli, et al.Pageof 102